Matyash Marina, Zabiegalov Oleksandr, Wendt Stefan, Matyash Vitali, Kettenmann Helmut
Cellular Neurosciences, Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Department of Neuropathology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
PLoS One. 2017 Apr 4;12(4):e0175012. doi: 10.1371/journal.pone.0175012. eCollection 2017.
Microglial cells invade the brain as amoeboid precursors and acquire a highly ramified morphology in the postnatal brain. Microglia express all essential purinergic elements such as receptors, nucleoside transporters and ecto-enzymes, including CD39 (NTPDase1) and CD73 (5'-nucleotidase), which sequentially degrade extracellular ATP to adenosine. Here, we show that constitutive deletion of CD39 and CD73 or both caused an inhibition of the microglia ramified phenotype in the brain with a reduction in the length of processes, branching frequency and number of intersections with Sholl spheres. In vitro, unlike wild-type microglia, cd39-/- and cd73-/- microglial cells were less complex and did not respond to ATP with the transformation into a more ramified phenotype. In acute brain slices, wild-type microglia retracted approximately 50% of their processes within 15 min after slicing of the brain, and this phenomenon was augmented in cd39-/- mice; moreover, the elongation of microglial processes towards the source of ATP or towards a laser lesion was observed only in wild-type but not in cd39-/- microglia. An elevation of extracellular adenosine 1) by the inhibition of adenosine transport with dipyridamole, 2) by application of exogenous adenosine or 3) by degradation of endogenous ATP/ADP with apyrase enhanced spontaneous and ATP-induced ramification of cd39-/- microglia in acute brain slices and facilitated the transformation of cd39-/- and cd73-/- microglia into a ramified process-bearing phenotype in vitro. These data indicate that under normal physiological conditions, CD39 and CD73 nucleotidases together with equilibrative nucleoside transporter 1 (ENT1) control the fate of extracellular adenosine and thereby the ramification of microglial processes.
小胶质细胞以阿米巴样前体细胞的形式侵入大脑,并在出生后的大脑中获得高度分支的形态。小胶质细胞表达所有必需的嘌呤能元件,如受体、核苷转运体和胞外酶,包括CD39(NTPDase1)和CD73(5'-核苷酸酶),它们依次将细胞外ATP降解为腺苷。在这里,我们表明,CD39和CD73或两者的组成性缺失导致大脑中小胶质细胞分支表型的抑制,其突起长度、分支频率和与肖尔球的交叉数量减少。在体外,与野生型小胶质细胞不同,cd39-/-和cd73-/-小胶质细胞的复杂性较低,并且不会因ATP而转变为更具分支的表型。在急性脑片中,野生型小胶质细胞在脑切片后15分钟内回缩了约50%的突起,这种现象在cd39-/-小鼠中更为明显;此外,仅在野生型小胶质细胞中观察到小胶质细胞突起向ATP源或激光损伤处的伸长,而在cd39-/-小胶质细胞中未观察到。通过以下方式提高细胞外腺苷水平:1)用双嘧达莫抑制腺苷转运,2)应用外源性腺苷,或3)用腺苷三磷酸双磷酸酶降解内源性ATP/ADP,可增强急性脑片中cd39-/-小胶质细胞的自发和ATP诱导的分支,并促进cd39-/-和cd73-/-小胶质细胞在体外转变为具有分支突起的表型。这些数据表明,在正常生理条件下,CD39和CD73核苷酸酶与平衡核苷转运体1(ENT1)共同控制细胞外腺苷的命运,从而控制小胶质细胞突起的分支。